Navigation Links
CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
Date:5/28/2008

PALO ALTO, Calif., May 28 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 31 non-executive officers due to additional hiring, primarily in connection with its commercialization efforts in the United States.

The inducement stock options cover an aggregate 151,800 shares of common stock and are classified as non-qualified stock options with an exercise price equal to the fair market value on the grant date. The options have a 10 year term and vest over four years as follows: 20 percent of these options will vest on the date one year from the optionee's hire date, 20 percent of the options will vest in monthly increments during each of the second and third years, and 40 percent of the options will vest in monthly increments during the fourth year (in all cases subject to the terms and conditions of CV Therapeutics 2004 Employment Commencement Incentive Plan).

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved products include Ranexa(R) (ranolazine extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan(TM) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. CV Therapeutics also has other cl
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... The chemistry, taste, and health effects of tea can vary ... the nonprofit American Botanical Council (ABC). Recent research by ... on the phytochemical compounds in tea ( Camellia sinensis ) ... in the Yunnan province of southwestern ... future of medicinal botanicals. Dr. Ahmed,s report on ...
(Date:9/15/2014)... La deuxième édition annuelle de l, ... sur la sensibilisation au plasma) sera célébrée du ... Plasma Protein Therapeutics Association (PPTA) et ... à : , Sensibiliser davantage la ... plasma-aphérèse , Reconnaître la contribution des donneurs ...
(Date:9/15/2014)... Hydro Dynamics, Inc. (HDI) of Rome, ... will be partnering with Proteaf Technologies (Proteaf) of ... implementing its Shock Wave Power Reactor (SPR) cavitation ... flow chemistry through process intensification has been widely ... for decades. The continuous chemistry has been ...
(Date:9/14/2014)... particularly ingenious when it comes to survival strategies. They ... hostile environment, for example during treatment with antibiotics. A ... a protective slime capsule consisting of sugar chains and ... have for the first time created a detailed three-dimensional ... blocks cross the bacterial cell wall, a crucial step ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... professionals often face the challenge of delivering cost-effective ... both storage and bandwidth efficiency, while providing seamless, ... SecureZip, a new family of products designed for ... a cross-platform environment. The company also introduced a ...
... Inc. announced Wednesday that its net sales are up ... The Milwaukee-based company, which does business as Merge ... the acquisition of RIS Logic, a radiology information systems ... eFilm's picture archiving and communication system, or PACS, used ...
... has announced a new network switch and router ... second, using designs bought from a Wisconsin company. , ... Eau Claire, designs application-specific integrated circuits and systems-on-a-chip. SLE ... System Packet Interface Level 4 Phase 2, or SPI ...
Cached Biology Technology:PKWare launches new enterprise product line, adds new features to PKZip 2PKWare launches new enterprise product line, adds new features to PKZip 3Agilent's new network chip was designed in Wisconsin 2
(Date:9/15/2014)... of wild, domesticated, and domesticated-wild hybridized populations ... found that within 5 to 11 generations, ... wild populations that hybridized with domesticated populations. ... provides evidence that natural selection, over time, ... experience as a result of increased genetic ...
(Date:9/15/2014)... Vuoksi River and the subsequent rapid decrease in the ... revealed thousands of square kilometres of new, fertile land ... University of Helsinki researchers has studied the role that ... interaction between nature and humans. After dramatic shifts in ... changes and gave rise to a new, innovative culture. ...
(Date:9/15/2014)... PA, September 15, 2014 Schizophrenia is generally considered ... shares many risk factors, both genetic and environmental, with ... , The normal path for brain development is determined ... genes and a wide range of environmental factors. , ... patient populations are required in order to map the ...
Breaking Biology News(10 mins):The creation of the Vuoksi River preceded a significant cultural shift 2Brain Development in Schizophrenia Strays from the Normal Path 2
... A mutation in blood stem cells occurs in patients ... at the Moores Cancer Center at the University of ... Cell Biology and Regenerative Medicine and Comprehensive Cancer Center ... The discovery suggests that development of a very specific ...
... colleagues have produced 3-D images of ancient fossils -- 650 ... an achievement that has never been done before. , If ... Earth, Schopf said the techniques he has used, called confocal ... look at microscopic fossils inside the rocks to search for ...
... bone may rely on a few secrets from the ... Berkeley National Laboratory (Berkeley Lab) have harnessed the way ... is four times stronger than material currently used in ... variations of this substance could also be used in ...
Cached Biology News:Mutation in blood stem cells provides clues to cancer development 2Mutation in blood stem cells provides clues to cancer development 3Inside rocks, implications for finding life on Mars 2Secrets of the sea yield stronger artificial bone 2Secrets of the sea yield stronger artificial bone 3Secrets of the sea yield stronger artificial bone 4
UBN-1 (C-20)...
P2A4...
pETDuet-1 is designed for the coexpression of two target genes....
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Biology Products: